1. United Nations Office on Drugs and Crime (UNODC). Current NPS Threats. Volume II, January 2020. UNODC Laboratory and Scientific Section, Vienna, 2020. Available from: https://www.unodc.org/documents/scientific/Current_NPS_Threats_Volume_II_Web.pdf
2. European Monitoring Centre for Drugs and Drug Addiction and Europol. EU Drug Markets Report. 2019. Publications Office of the European Union, Luxembourg, 2019. Available from: http://www.emcdda.europa.eu/system/files/publications/12078/20192630_TD0319332ENN_PDF.pdf
3. European Monitoring Centre for Drugs and Drug Addiction. Perspectives on drugs. Synthetic cannabinoids in Europe. EMCDDA, Lisbon, 2017. Available from: http://www.emcdda.europa.eu/system/files/publications/2753/POD_Synthetic%20cannabinoids_0.pdf
4. Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation
5. Effects of lipophilicity and functional groups of synthetic cannabinoids on their blood concentrations and urinary excretion